Analgesic and cardiovascular effects of centrally administered substance P.
Substance P (SP) injected intracerebroventricularly (ICV) into rabbits caused dose-related thermal analgesia with the maximum effect after 2 micrograms. The analgesia was measured by timing the withdrawal of the rabbit's ear from an infrared beam. Equimolar amounts of the related peptides physalaemin and eledoisin-related peptide also caused analgesia, but the SP N-terminal fragment (1-9) was inactive. This suggests that the analgesic message of SP resides within the C-terminal fragment. The analgesia caused by each peptide developed more rapidly but did not last as long as that after central injection of beta-endorphin. In separate experiments, 2 micrograms SP injected ICV increased blood pressure and decreased heart rate. The analgesic, bradycardic and pressor responses to central administration of SP were opposite to effects of peripherally administered SP, described previously. These results indicate that the effect induced by SP depends upon its specific neuroanatomical site of action.
Clint
B D
BD
Department of Anesthesiology and Physiology, University of Texas Southwestern Medical Center, Dallas 75235.
Lipton
J M
JM
Giesecke
A H
AH
D000698:Analgesia; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects*; D006358:Hot Temperature; D007276:Injections, Intraventricular; D008297:Male; D011817:Rabbits; D012016:Reference Values; D013373:Substance P / Q000008:administration & dosage / Q000494:pharmacology*
D013373:Substance P